Welcome to our dedicated page for Steris Plc news (Ticker: STE), a resource for investors and traders seeking the latest updates and insights on Steris Plc stock.
News and updates about STERIS plc (NYSE: STE) focus on its role as a medical technology company that supports patient care with an emphasis on infection prevention. The company regularly issues press releases from Dublin, Ireland, describing its financial performance, dividends, leadership changes and investor events, giving readers insight into how its healthcare and life science products and services business is developing.
Investors following STERIS news can expect recurring coverage of quarterly and annual financial results, where the company reports total revenue from continuing operations, segment performance for Healthcare, Applied Sterilization Technologies (AST) and Life Sciences, and both GAAP and non-GAAP metrics such as adjusted earnings per diluted share and free cash flow. These releases often include management commentary and an outlook for future fiscal periods, along with detailed explanations of non-GAAP measures.
STERIS news also includes announcements of quarterly dividends, with information on dividend amounts, payment dates and record dates. Some releases highlight the company’s history of dividend growth. Governance and leadership developments, such as transitions in the Chief Financial Officer role or changes to the Board of Directors, are disclosed through both press releases and related SEC filings, and are frequently summarized in the news flow.
In addition, STERIS routinely announces conference calls to discuss financial results, providing access details and replay information for investors and analysts. Each release typically contains a cautionary statement regarding forward-looking information and references to risk factors described in the company’s SEC filings. Readers who monitor this news stream can follow how STERIS communicates its financial performance, strategic outlook, shareholder returns and governance matters over time.
STERIS (NYSE: STE) will host a conference call to discuss fiscal 2026 fourth quarter and full year results at 9:00 a.m. ET on May 12, 2026.
A press release with financial results will be issued after U.S. market close on May 11, 2026. Live webcast and replay details, phone numbers, and access codes are provided for investor access.
Teleflex (NYSE:TFX) announced Board and governance changes on April 9, 2026, including the nomination of Michael J. Tokich as an independent director and the appointment of Andrew A. Krakauer as Chairman effective after the 2026 Annual Meeting.
The Board will form a Growth and Operating Committee to support transformation efforts, and the company plans to commence opportunistic share repurchases under its existing $1 billion authorization beginning in Q2 2026, subject to market conditions and cash flow needs.
STERIS (NYSE: STE) reported fiscal 2026 third-quarter continuing‑operations revenue of $1.5 billion, up 9% year‑over‑year, with constant currency organic growth of 8%. As‑reported EPS was $1.96; adjusted EPS was $2.53. Nine‑month free cash flow reached $737.6 million. Fiscal 2026 outlook was maintained, with adjusted EPS guidance of $10.15–$10.30 and revenue growth of 8–9%.
STERIS (NYSE: STE) announced a quarterly cash dividend of $0.63 per share, payable March 19, 2026, to shareholders of record at the close of business on February 17, 2026.
The company provided guidance on U.S. tax treatment and referenced Forms 8937 for additional tax information.
STERIS (NYSE: STE) will host a conference call to discuss its fiscal 2026 third quarter results at 9:00 a.m. ET on February 5, 2026. A related press release with financial results will be issued after U.S. market close on February 4, 2026. Investors can listen live at www.steris-ir.com or by phone at 1-833-535-2199 (U.S.) or 1-412-902-6776 (international). A replay will be available beginning 12:00 p.m. ET on February 5, 2026 at www.steris-ir.com or by phone using access code 7731965 (U.S. replay dial-in: 1-855-669-9658; international replay: 1-412-317-0088).
Mettler-Toledo (NYSE: MTD) announced that Michael J. Tokich will join its Board of Directors, effective February 5, 2026. Mr. Tokich served more than 17 years as Senior Vice President and Chief Financial Officer at STERIS and recently transitioned to Senior Financial Advisor at STERIS. He joined STERIS in 2000 and became CFO in 2008. Board Chair Roland Diggelmann highlighted Tokich’s nearly two decades of U.S. public company CFO experience and said his financial, operational, and IT expertise will add value to Mettler-Toledo’s oversight. The company reiterated its global leadership in precision instruments and broad sales and service network across approximately 40 direct-presence countries.
STERIS (NYSE: STE) reported fiscal 2026 second quarter results: total revenue $1.5B (+10% YoY) and constant-currency organic revenue +9%. As-reported EPS from continuing operations was $1.94; adjusted EPS $2.47 vs $2.14 year-ago. Segment performance: Healthcare revenue $1,033.8M (+9%), AST $281.5M (+10%) with a 76% decline in capital equipment, and Life Sciences $145.0M (+13%).
Cash: H1 operating cash $707.8M and free cash flow $527.7M (H1). Company raised fiscal 2026 guidance: constant-currency organic revenue now +7–8%, adjusted EPS $10.15–10.30, and free cash flow ~ $850M; tariffs still estimated to cut pre-tax profit by ~$45M and effective tax rate ~24%.
STERIS (NYSE: STE) announced a quarterly cash dividend of $0.63 per share, payable on December 18, 2025 to shareholders of record as of November 18, 2025. The company noted U.S. tax-treatment information and Forms 8937 are available on its investor website.
The release reiterates forward-looking cautionary language about risks that could affect future results, including operating costs, integration of acquisitions, litigation, and macroeconomic factors.
STERIS (NYSE: STE) will host a conference call to discuss its fiscal 2026 second quarter results at 9:00 a.m. ET on November 6, 2025. A press release with financial results will be issued after the U.S. market close on November 5, 2025. The live call is available at www.steris-ir.com or by phone (US: 1-800-715-9871; international: 1-646-307-1963). A replay will be available beginning 12:00 p.m. ET on November 6, 2025 via the investor site or by phone using access code 2170300 (US replay: 1-877-344-7529; international replay: 1-412-317-0088).
STERIS plc (NYSE: STE) announced a significant leadership transition as long-time Chief Financial Officer Michael J. Tokich steps down after 17 years in the role. Karen L. Burton, currently Vice President and Chief Accounting Officer, will succeed Tokich as Senior Vice President and CFO effective August 18, 2025.
Under Tokich's tenure as CFO since 2008, STERIS has experienced remarkable growth, with revenue quadrupling and market capitalization increasing from $1 billion to $22 billion. Tokich will transition to the role of Senior Financial Advisor, reporting to the CEO. Burton, who has been with STERIS since 2004 and served as CAO since 2017, will oversee all global finance functions and IT in her new role.